OpenLegislation

Article 3 F1

United Kingdom

Original text. Later amendments are not shown.

1.

On the basis of a favourable result of the appraisal of an applicant laboratory in a F2part of Great Britain, any relevant competent authority may authorise the applicant laboratory to carry out the serological tests to monitor the effectiveness of rabies vaccines.

F3 The Secretary of State, with the consent of the Welsh Ministers and the Scottish Ministers must draw up, keep up to date and publish a list of those laboratories that have been so authorised.

2.

On the basis of a favourable result of the appraisal of an applicant laboratory in a third country F4..., and following an application for approval from the competent authority of the third country of origin of the applicant laboratory, such laboratory shall be authorised F5... to carry out serological tests to monitor the effectiveness of rabies vaccines.

2A.

F6In this Article and in Annex 2—

(a)

“the relevant competent authorities” means—

(i)

in relation to England, the Secretary of State;

(ii)

in relation to Scotland, the Scottish Ministers;

(iii)

in relation to Wales, the Welsh Ministers;

(b)

“third country” means any country other than the United Kingdom.

F73.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations

Textual amendments

F1

Substituted by Council Directive 2008/73/EC of 15 July 2008 simplifying procedures of listing and publishing information in the veterinary and zootechnical fields and amending Directives 64/432/EEC, 77/504/EEC, 88/407/EEC, 88/661/EEC, 89/361/EEC, 89/556/EEC, 90/426/EEC, 90/427/EEC, 90/428/EEC, 90/429/EEC, 90/539/EEC, 91/68/EEC, 91/496/EEC, 92/35/EEC, 92/65/EEC, 92/66/EEC, 92/119/EEC, 94/28/EC, 2000/75/EC, Decision 2000/258/EC and Directives 2001/89/EC, 2002/60/EC and 2005/94/EC (Text with EEA relevance).

F2

Words in Art. 3(1) substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(a) (as amended by S.I. 2020/1388, regs. 1(2)(a), 25(2)(a)); 2020 c. 1, Sch. 5 para. 1(1)

F3

Words in Art. 3(1) substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(b) (as amended by S.I. 2020/1388, regs. 1(2)(a), 25(2)(b)); 2020 c. 1, Sch. 5 para. 1(1)

F4

Words in Art. 3(2) omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(c)(i); 2020 c. 1, Sch. 5 para. 1(1)

F5

Words in Art. 3(2) omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(c)(ii); 2020 c. 1, Sch. 5 para. 1(1)

F6

Art. 3(2A) inserted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(d) (as amended by S.I. 2020/1388, regs. 1(2)(a), 25(2)(c)) ; 2020 c. 1, Sch. 5 para. 1(1)

F7

Art. 3(3) omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(e); 2020 c. 1, Sch. 5 para. 1(1)